Amoxicillin And Clavulanate Potassium Powder, For Suspension
Product Images NDC 0093-2277

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 0093-2277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

FDA Label Image

Image 2

FDA Label Image

Image 3

Image 3
This is a description of a medication with the National Drug Code (NDC) of 0093-2274-34. It is a tablet that contains a combination of Amoxicillin and Clavulanate Potassium, with a strength of 500mg/125mg. The tablets have a USP (United States Pharmacopeia) content of 0.53 mEq potassium. The usual dosage information can be found in the package insert. The medication should be kept out of reach of children. It is manufactured in Canada by Teva Canada Limited. The package contains 20 tablets, and the revision date for the contents is October 2014.*
FDA Label Image

Image 4

FDA Label Image

Image 5

Image 5
This is the description of a medication with the NDC code 0093-2277-73. It is an oral suspension containing Amoxicillin and Clavulanate Potassium with a dosage of 200mg/28.5mg per 5mL. When reconstituted, 100mL of the medication will be produced. Additional information is presented but it is unclear due to poor quality.*
FDA Label Image

Image 6

Image 6
Not available.*
FDA Label Image

Image 7

Image 7
This is a description of Lavulanate Potassium chewable tablets with a strength of 200mg/28.5mg. The tablets are only available with a prescription and the NDC code is 0093-2270-34. The GTIN code is 0030032270343 and the revision date is C10/2014. The tablets are produced by TevaPharmaceuticals USA Inc. with the address Rorth Wales, PA 19454. There is additional unreadable information related to the LOT and EXP of the tablets.*
FDA Label Image

Image 8

Image 8
This is a description of Lavulanate Potassium Chewable Tablets USP, containing 400 mg/57 mg of a medicinal ingredient. The pack contains 20 chewable tablets, which are identified by the code TIN 0030932272347. The details are listed on the pack of the tablets, and the manufacturer's address is mentioned as Horth Wales, PA, 19454.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.